Over 1 million people vaccinated against Covid-19 within 10 days in US

Shots are rolling out from Pfizer Inc. and Moderna Inc., focused at first on hundreds of thousands of health-care workers around the country

Vaccine, US Vaccination, Pfizer Vaccine
Urgency is rising as a wave of winter infections washes over the northern hemisphere.
Tom Randall and Drew Armstrong | Bloomberg
2 min read Last Updated : Dec 24 2020 | 10:20 AM IST
The U.S. now leads the world in Covid-19 vaccine shots administered, with more than 1.12 million doses given in the first 10 days of its campaign, according to state-by-state data compiled by Bloomberg.

Three states have now vaccinated more than 1% of their populations: North Dakota, West Virginia, and Alaska. California leads in total vaccinations at 128,000 shots. The numbers fall short of a U.S. goal to administer 20 million shots in 2020, U.S. officials acknowledged Wednesday. That amount will be disbursed to states by the end of the month, but not in time to be administered.

Shots are rolling out from Pfizer Inc. and Moderna Inc., focused at first on hundreds of thousands of health-care workers around the country who have been battling the virus on the front lines in hospitals. The vaccines require two shots weeks apart to deliver the highest level of protection.

Urgency is rising as a wave of winter infections washes over the northern hemisphere. New variants of the disease have been detected in the U.K. and South Africa. The mutations appear to make the virus more contagious and may be increasing infections among healthy young people. In the U.S., more than 2,500 people are dying every day.

China, which has several home-grown vaccines, said on Dec. 19 that it had reached the million-dose milestone. That figures include some people who have already taken the second dose. Russia has vaccinated 440,000 people. Both countries got a head start in August by authorizing domestically produced vaccines before they’d been fully tested.

The U.K. is also making rapid progress delivering the shots and is expected to provide an update on its tally as soon as Wednesday afternoon.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccinePfizer

Next Story